quantrifat

RGEN

做多
quantrifat 已更新   
NASDAQ:RGEN   Repligen Corporation
First Half 2019 Highlights--
Revenue increased by 42% year-over-year, and 42% organically, to $131.3 million
GAAP income from operations increased 580 bps to 16.9% of revenue
Adjusted (non-GAAP) income from operations increased 870 bps to 27.2% of revenue
GAAP fully-diluted EPS increased to $0.34 compared to $0.14 for the first half of 2018

Adjusted (non-GAAP) fully-diluted EPS increased to $0.59 compared to $0.29 for the first half of 2018

Buy Zone: $81.45 to $77.96
Stop loss: Daily close below $76.70
Target: $99+
交易开始:
adjust the stop loss::-- daily close below $77.33 area.
交易开始:
sorry for the typing error... stop loss is daily close below 76.33 area
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。